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Mr. Editor
I have read the article “Comparison of APACHE II scales and BISAP in the prognosis of acute pancreatitis in
a hospital in Peru ”by García-Revilla et al(1), where they make a comparison of both scales in the prognosis
of organ failure in hospitalized patients with acute pancreatitis in a public hospital in Peru. In this context,
I would like to comment on the methodology used in this article.
We know that to evaluate the severity in patients with acute pancreatitis, we have the APACHE II scale,
which is the gold standard and is used as a comparator for assessing other scales. Remember that it
evaluates the physiological variables which reveal the state of organ failure and has a second part where
the patient's comorbidities are considered(4), we also have the BISAP scale, which assesses five variables:
urea nitrogen values, age, consciousness compromise, presence of pleural effusion and inflammatory
response syndrome (SIRS)(2); These scales share values such as heart rate, respiratory rate, and temperature,
it is these variables that will be influenced by chronic pathologies such as cardiovascular, respiratory,
kidney or oncological diseases, among others.
In this context, we must remember that non-communicable diseases kill 71% of the population between
30 and 70 years of age worldwide; deaths from cardiovascular diseases represent the majority of cases
(17.9 million people per year), followed by oncological diseases (9 million per year) and respiratory
diseases (3.9 million)(3), in Peru non-communicable diseases represent 58.5% of the diseases with the
highest incidence and generate greater disability(4).
Therefore, the study mentions the exclusion of patients with any pathology that increases the length
of hospital stay, such as chronic kidney failure, chronic obstructive pulmonary disease, heart disease,
oncological diseases, and those with a history of chronic pancreatitis. Compared to other studies on
the same topic, where this type of exclusion does not apply, the question arises: Why do the authors
exclude patients with comorbidities? We do know that these pathologies increase the morbidity and
mortality of the subject, aggravating their initial state in the face of inflammatory processes, such as
acute pancreatitis, and more if an infectious process is added.
For example, in a Peruvian study carried out by Pérez et al,5where they do not perform any type of
exclusion, they obtain that the area under the curve (AUC) for the APACHE II scale is 0.854, the sensitivity
is 85.71%, the specificity is 76.14%, while the AUC for BISAP is 0.872, sensitivity of 60.71%, specificity of
91.83%, they conclude that these scales can be applied to identify patients with low risk of severity; In
another study carried out by Harshit et al,6with similar methodology, an AUC for APACHE II is 0.855,
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Making a comparison of these two studies, both with
small sample size, it is observed that the study by
Harshit et al(6) was able to predict the development of
severe disease in patients, while the study by GarcíaRevilla et al(1) point out that had a low frequency of
patients with severe acute pancreatitis, limiting their
predictive power for the severity of the condition,
this could be explained by the exclusion of patients
with comorbidities, rather than by the small sample
size since patients with chronic diseases aggravate
the condition initial reason why they have a greater
probability of organ failure.
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It is necessary to remember the importance of the
selection criteria when proposing diagnostic studies,
considering the implications of excluding certain
patients.
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sensitivity of 92.86%, specificity of 69.44%, the
AUC for BISAP 0.822 with a sensitivity of 90% and
specificity Of 83.87%, due to the small sample size,
they are limited in giving statements about the
usefulness of the scales to predict organ failure, they
only conclude that the APACHE II scale is a useful
tool to predict the development of serious disease;
while García-Revilla et al(1), where they applied the
exclusion criterion of patients with comorbidities,
obtained an AUC for APACHE II is 0.996, sensitivity
of 66%, specificity of 99%, the AUC for BISAP 0.957,
sensitivity of 83%, specificity of 99%, so although in
the study they obtain very favorable results as they
have an AUC very close to unity, which indicates its
high sensitivity and specificity, they also indicate
that the severity of the condition is associated with a
longer hospital stay.
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